Lansoprazole
Back to searchMolecule Structure
Scientific Name
Lansoprazole
Description of the Drug
Lansoprazole is a proton pump inhibitor used to help gastrointestinal ulcers heal, to treat symptoms of gastroesophageal reflux disease (GERD), to eradicate Helicobacter pylori, and to treat hypersecretory conditions such as Zollinger-Ellison Syndrome.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00448
http://www.drugbank.ca/drugs/DB00448
Brand Name(s)
Lansoprazole, Opiren, Prevacid, Prevacid 24 hr, Prevacid Delayed Release, Prevacid iv, Prevacid Solutab, Zoton
Company Owner(s)
Alkem Laboratories Ltd, Takeda Pharmaceuticals Usa Inc, Mylan Pharmaceuticals Inc, Atlantide Pharmaceuticals Ag, Zydus Pharmaceuticals Usa Inc, Inventia Healthcare Ltd, Rising Pharma Holdings Inc, Perrigo R And D Co, Ajanta Pharma Ltd, Ani Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Potassium-transporting ATPase | PROTEIN COMPLEX | INHIBITOR | CHEMBL2095173 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL22365 | |
| PharmGKB | PA450180 | |
| Human Metabolome Database | HMDB0005008 | |
| DrugBank | DB00448 | |
| PubChem: Thomson Pharma | 14852955 | |
| PubChem | 3883 | |
| Mcule | MCULE-8446262134 | |
| NMRShiftDB | 60061656 | |
| LINCS | LSM-5064 | |
| Nikkaji | J126.212B | |
| BindingDB | 47032 | |
| EPA CompTox Dashboard | DTXSID4023200 | |
| DrugCentral | 1547 | |
| Brenda | 4413 | |
| ChemicalBook | CB6396972 | |
| Guide to Pharmacology | 7208 | |
| rxnorm | LANSOPRAZOLE | PREVACID |
| PubChem: Drugs of the Future | 12013895 | |
| ChEBI | 6375 |
